Omalizumab in an allergology clinic: real life experience and future developments

Omalizumab is a recombinant humanized monoclonal antibody that reduces levels of circulating IgE and expression of IgE high affinity receptor (FCɛRI) on mast cells and basophils. Its role in the therapy of allergic asthma and urticaria is well established. According to GINA guidelines, omalizumab sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupczyk, Maciej, Kuna, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952053/
https://www.ncbi.nlm.nih.gov/pubmed/24683395
http://dx.doi.org/10.5114/pdia.2014.40657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952053/
https://www.ncbi.nlm.nih.gov/pubmed/24683395
http://dx.doi.org/10.5114/pdia.2014.40657

Ejemplares similares